Fulcrum Therapeutics | 4:持股变动声明-高管 Tourangeau Greg
Fulcrum Therapeutics | 4:持股变动声明-高管 Horn Patrick Taylor
Fulcrum Therapeutics | 3:首次持股声明-高管 Horn Patrick Taylor
Fulcrum Therapeutics | 4:持股变动声明-高管 Tourangeau Greg
Fulcrum Therapeutics | 4:持股变动声明-高管 Sapir Alex
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Third Rock Ventures IV, L.P.(3.8%),Third Rock Ventures GP IV, L.P.(3.8%)等
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(18.8%),Peter Kolchinsky(18.8%)等
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(8.9%),Aaron Cowen(8.9%)等
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(9.195%),Abigail P. Johnson(9.195%)
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Adage Capital Partners, L.P.(2.44%),Adage Capital Partners GP, L.L.C.(2.44%)等
Fulcrum Therapeutics | 4:持股变动声明-高管 Tourangeau Greg
Fulcrum Therapeutics | 4:持股变动声明-高管 Musso Alan A
Fulcrum Therapeutics | 4:持股变动声明-高管 Oltmans Curtis Gale
Fulcrum Therapeutics | 4:持股变动声明-高管 Musso Alan A
Fulcrum Therapeutics | 4:持股变动声明-首席财务官 Musso Alan A
Fulcrum Therapeutics | 3:首次持股声明-首席财务官 Musso Alan A
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(2.5%)
Fulcrum Therapeutics | 3:首次持股声明-高管 Sapir Alex
Fulcrum Therapeutics | 4:持股变动声明-董事 GERAGHTY JAMES A
暂无数据